Testosterone and Growth Hormone Supplements Not Recommended for Surgery Patients
Editorial warns against routine use of testosterone, growth hormone, and vitamin D supplements in orthopedic surgery patients despite potential benefits.
Summary
An editorial commentary argues against routine supplementation with testosterone replacement therapy (TRT), growth hormone, and vitamin D for orthopedic surgery patients. While these supplements may offer benefits like improved bone density, muscle mass, and surgical recovery, the author emphasizes that risks outweigh benefits for routine perioperative use. Patients increasingly request these supplements believing they enhance healing, but evidence doesn't support routine prescription. The commentary highlights the need for careful risk-benefit analysis rather than blanket supplementation approaches in surgical settings.
Detailed Summary
This editorial commentary addresses the growing trend of patients requesting hormone and vitamin supplementation around orthopedic surgeries, arguing against routine use despite potential benefits. The piece examines why this matters as aging populations increasingly seek interventions to optimize surgical outcomes and recovery.
The commentary reviews testosterone replacement therapy (TRT), which endocrinologists prescribe for aging males with low androgens to improve mood, cognition, libido, and quality of life. In surgical contexts, TRT might theoretically enhance bone density, lean muscle mass, and early mobilization. Similarly, vitamin D supplementation could benefit fracture healing and tissue repair, while growth hormones like BPC-157 might optimize recovery and tissue repair.
However, the author concludes that routine supplementation isn't justified for orthopedic surgery patients. The editorial emphasizes that while these supplements show promise in specific populations, the risks and lack of evidence for routine perioperative use outweigh potential benefits.
The implications suggest clinicians should resist patient pressure for routine supplementation and instead focus on evidence-based perioperative care. This challenges the growing 'optimization' mindset in surgical preparation, advocating for more conservative, individualized approaches to supplement use in surgical settings.
Key Findings
- TRT not recommended for routine perioperative orthopedic surgery management
- Vitamin D and growth hormone supplements lack evidence for routine surgical use
- Patient requests for supplements increasing despite insufficient evidence
- Risks of routine supplementation may outweigh theoretical benefits
- Individual risk-benefit analysis needed rather than blanket supplementation
Methodology
This is an editorial commentary rather than an original research study. The author provides clinical perspective on supplement use in orthopedic surgery based on existing literature and clinical experience.
Study Limitations
As an editorial commentary, this represents expert opinion rather than new research data. Limited to abstract-only analysis without access to full argumentation and supporting evidence cited by the author.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.